BOSCARINO, MARCO
BOSCARINO, MARCO
Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti
Evaluation of different platelet-dependent von Willebrand factor activity assays to assess the in vivo inhibitory effect of caplacizumab on the von Willebrand factor–platelet interaction
2025 P. Colpani, L. Baronciani, I. Mancini, C. Novembrino, A. Lecchi, G. Cozzi, P. De Leo, M.B. Anzoletti, S. La Marca, M. Boscarino, M.T. Pagliari, A. Artoni, F. Peyvandi
Flow-chamber device (T-TAS) to diagnose patients suspected of platelet function defects
2024 A. Lecchi, S. La Marca, L. Padovan, M. Boscarino, F. Peyvandi, A. Tripodi
Erratum to ‘A comparative study in type 2 von Willebrand disease patients using four different platelet-dependent von Willebrand factor assays.’ [Research and Practice in Thrombosis and Haemostasis Volume 7, Issue 3, March 2023, 100139]
2023 P. Colpani, L. Baronciani, F. Stufano, G. Cozzi, M. Boscarino, M.T. Pagliari, E. Biguzzi, F. Peyvandi
Lombardy diagnostic and therapeutic network of thrombotic microangiopathy
2022 I. Mancini, P. Agosti, M. Boscarino, B. Ferrari, A. Artoni, R. Palla, M. Spreafico, G. Crovetti, E. Volpato, S. Rossini, C. Novelli, S. Gattillo, L. Barcella, M. Salmoiraghi, A. Falanga, F. Peyvandi, L. Russo, L. Barcella, E. Capuzzo, M. D'Agostino, P. Moreno, I. Alessandro, P. Ambrogio
Real‐world data on emicizumab prophylaxis in the Milan cohort
2022 S. Arcudi, R. Gualtierotti, S. Marino, G. Nicolò, E. Biguzzi, A. Ciavarella, M. Boscarino, S.M. Siboni, L. Schiavone, C. Novembrino, C. Valsecchi, F. Peyvandi
Role of ADAMTS13, VWF and F8 genes in deep vein thrombosis
2021 M.T. Pagliari, A. Cairo, M. Boscarino, I. Mancini, E. Pappalardo, P. Bucciarelli, I. Martinelli, F.R. Rosendaal, F. Peyvandi